# Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2025

- Company: [Fresenius Medical Care AG](/companies/fms.md) (CIK 1333141)
- Form: 20-F
- Filed: 2026-02-24
- Accepted by EDGAR: Feb 24, 2026, 12:41 ET
- Period: 2025-12-31
- Accession: 0001104659-26-019005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1333141/000110465926019005/fms-20251231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1333141/000110465926019005/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | EUR 19.63bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | EUR 14.60bn | ifrs-full:CostOfSales |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | EUR 1.83bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | EUR 321.0m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | EUR 978.4m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | EUR 3.36 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | EUR 3.36 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | EUR 2.68bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2025-12-31 | EUR 1.60bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2025-12-31 | EUR 7.90bn | ifrs-full:CurrentAssets |
| Total assets | at 2025-12-31 | EUR 31.00bn | ifrs-full:Assets |
| Current liabilities | at 2025-12-31 | EUR 6.25bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2025-12-31 | EUR 16.72bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2025-12-31 | EUR 13.31bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2025-12-31 | 279,288,885 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1333141/000110465926019005/fms-20251231x20f.htm

Filed Feb 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-019005. Last ingested by Listed: Nov 10, 2026, 00:27 ET. No prices; not investment advice.